crisprtx.com (CRSP) - Company Sales Revenue

Corporate emblem and logo of CRISPR Therapeutics (CRSP)

The sales development vector for CRISPR Therapeutics AG (CRSP) on GURU.Markets contains a value fixed at 0.03. The genome editing leader is implementing Casgevy and CAR-T therapies, leveraging solid reserves. However, long-term side effects and the high cost of drugs are constraining demand. Current success is based on the effectiveness of new product commercialization and streamlined logistics, supported by a stable liquidity reserve.

CRSP CRISPR: Company Revenue in the range 07/04/2022 - 11/18/2026

Analytical breakdowns for CRISPR Therapeutics AG

- share price and consensus valuation forecast:
Summary company analysis:CRSP (CRISPR Therapeutics)
Core merchandise of crisprtx.com

To objectively evaluate an issuer, it is essential for a portfolio manager to track the dynamics of daily revenue from product sales, which helps determine the asset's fundamental support level. By analyzing the revenue chart for CRISPR Therapeutics AG (CRSP), an investor can see the actual cash flow, which for CRISPR Therapeutics AG (CRSP) does not depend on macroeconomic cycles but is determined exclusively by FDA drug approval stages and the success of clinical trials.

Competing companies

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|genedx.com - Revenue and Sales Volume|Company Sales Revenue RARE (ultragenyx.com)|BEAM: Revenue and Sales Volume|Sarepta - Company Sales Revenue|TWST (twistbioscience.com) - Revenue and Sales Volume|Company Sales Volume TXG (10x Genomics Corp)|Revenue and Sales Volume NTLA|Revenue and Sales Volume Stoke Therapeutics, Inc. (STOK)|Company Revenue BioLife BLFS|WVE - Company Sales|Maze Therapeutics Corp - Revenue and Sales Volume|Sionna Pharma - Company Total Sales|Prime Medicine (PRME) - Company Revenue|tayshagtx.com (TSHA) - Revenue and Sales Volume|Company Revenue uniQure Corp|MGTX: Company Sales Revenue|Revenue and Sales Volume RGNX|Company Gross Revenue Solid Corp|Revenue and Sales Volume OCGN (ocugen.com)|PACB (Pacific Biosciences) - Company Annual Revenue|Benitec Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Company Revenue|4D Molecular Therapeutics (FDMT) - Revenue and Sales Volume|LXEO (Lexeo Therapeutics, Inc.) - Revenue and Sales Volume|Company Total Revenue korrobio.com KRRO|Company Sales EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Company Sales Volume|Company Revenue ProQR Therapeutics N.V. PRQR|Company Gross Revenue Codexis, Inc. (CDXS)|SGMO - Company Revenue|nautilus.bio - Company Total Sales|Metagenomi, Inc (MGX) - Company Revenue|Company Sales Volume DTIL|Company Revenue Generation Bio|Revenue and Sales Volume Boundless Bio Inc|Company Revenue Exicure Corp (XCUR)|Company Gross Revenue Imunon|Revenue and Sales Volume PHIO (phiopharma.com)|Company Total Sales Volume mustangbio.com|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales